A study reveals a 14-gene assay guides chemotherapy decisions effectively in patients with early-stage non-small cell lung cancer (NSCLC).
David Spigel, MD
Advertisement
Articles by David Spigel, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
From Stigma to Breakthrough: Psychedelic Medicine
2
CHEST 2025: Brensocatib Shows Potential to Slow Structural Lung Changes in Bronchiectasis
3
Pharmacists Can Drive Equitable Diagnostics Access, Improve Antimicrobial Resistance Stewardship
4
In the Fragmented Landscape of Long COVID Care, Pharmacists Are Essential
5
